Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003069923 | SCV003470694 | pathogenic | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2021-04-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp314Glufs*4) in the MKKS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKKS are known to be pathogenic (PMID: 11179009, 28761321, 30614526). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MKKS-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003475506 | SCV004194910 | likely pathogenic | Bardet-Biedl syndrome 6 | 2022-07-14 | criteria provided, single submitter | clinical testing |